Lara Mae Gonzales, Sarah Jane Datay-Lim, E. A. Alcazaren
{"title":"菲律宾原发性乳腺癌患者的临床病理特征与根据 ASCO/CAP 2018 年乳腺癌 HER2 检测指南划分的 HER2 亚组的相关性","authors":"Lara Mae Gonzales, Sarah Jane Datay-Lim, E. A. Alcazaren","doi":"10.21141/pjp.2023.18","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":166708,"journal":{"name":"Philippine Journal of Pathology","volume":"23 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correlation of Clinicopathologic Features of Filipino Primary Breast Cancer Patients with HER2 Subgroups Classified according to the ASCO/CAP 2018 Breast Cancer HER2 Testing Guidelines\",\"authors\":\"Lara Mae Gonzales, Sarah Jane Datay-Lim, E. A. Alcazaren\",\"doi\":\"10.21141/pjp.2023.18\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":166708,\"journal\":{\"name\":\"Philippine Journal of Pathology\",\"volume\":\"23 11\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Philippine Journal of Pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21141/pjp.2023.18\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Philippine Journal of Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21141/pjp.2023.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Correlation of Clinicopathologic Features of Filipino Primary Breast Cancer Patients with HER2 Subgroups Classified according to the ASCO/CAP 2018 Breast Cancer HER2 Testing Guidelines